Example logo GIS 26

Global Innovation Summit 2026

6 May 2026 | Basel, Switzerland

Home
Register
Register
Register

Project cooperationUpdated on 17 February 2026

EU work packages to accelerate Phase I readiness

Ramtin Rahbar

Co-founder and Chief Technical Officer at Ness Therapeutics

Toronto, Canada

About

Ness Therapeutics is seeking EU partners to lead defined optimization work packages that accelerate Phase I readiness for N001, a self-administered intranasal, host-directed, virus-agnostic prophylactic medical countermeasure for URTI viruses.

Priority optimization work packages include:

  • Potency and functional assay optimization suitable for clinical-stage decision-making

  • Respiratory biomarker and translational readout strategy, including sampling and analysis plans

  • Phase I execution support, including protocol-ready operational planning and site readiness inputs

  • Regulatory support aligned with EU clinical expectations

We prefer partners who can commit to clear deliverables, tight timelines, and high-quality documentation. Details can be shared under CDA.

Stage

  • Execution

Topic

  • Biotech, Pharma and Cosmetics

Type

  • Technical

Organisation

Ness Therapeutics

SME

Toronto, Canada

Similar opportunities